EP Patent

EP4234036A3 — Multi-unit drug delivery devices

Assigned to Taris Biomedical LLC · Expires 2023-11-01 · 3y expired

What this patent protects

The present invention relates to an intravesical drug delivery device comprising: a first housing portion loaded with a drug formulation which comprises a drug; and a second housing portion loaded with an excipient, wherein the device is configured to release the drug according …

USPTO Abstract

The present invention relates to an intravesical drug delivery device comprising: a first housing portion loaded with a drug formulation which comprises a drug; and a second housing portion loaded with an excipient, wherein the device is configured to release the drug according to a first release profile and is configured to release the excipient according to a second release profile which differs from the first release profile.

Drugs covered by this patent

Patent Metadata

Patent number
EP4234036A3
Jurisdiction
EP
Classification
—
Expires
2023-11-01
Drug substance claim
No
Drug product claim
No
Assignee
Taris Biomedical LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.